BEGIN:VCALENDAR PRODID;X-RICAL-TZSOURCE=TZINFO:-//com.denhaven2/NONSGML ri_cal gem//EN CALSCALE:GREGORIAN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:You read and hear about it again and again: Early stage inves tment is nearly impossible to get. But we know that to be untrue. It IS possible for an early stage life science or technology company to attrac t investment\, but it requires the right questions\, the right opportuni ty and the right preparation. \;A panel moderated by Frederic Morris partner and founder at Brook Venture Partners and consisting of Caleb W inder\, Director of leading life sciences venture capital firm Excel Med ical Ventures\; Eric Gordon\, CEO of Atentiv which provides personalized digital learning tools for the permanent remediation of ADHD through an EEG-based direct brain computer interface\; and Chris Stepanian\, CEO o f WindGap Medical\, which is developing a compact auto-injector for emer gency medical interventions\, will unravel the mystery of how successful venture or angel funding is accomplished \; at the North Shore Tech nology Council February breakfast event. \; Sponsored by Pepper Hami lton\, LLP.\n \;\nOUR SPEAKERS:\nCaleb Winder\, Director Excel Medic al Ventures\, has over 15 years of operating and startup experience in l ife science and healthcare companies. He represents Excel as a Board Mem ber for Aventura and Cleveland HeartLab and is a Board Observer for Sala dax and MedVentive. Caleb plays an instrumental role in sourcing and str ucturing deals and works closely with portfolio companies to form strate gic partnerships.\nPrior to joining Excel\, Caleb was a Principal at Bio techonomy\, where he worked to identify\, finance\, and manage several e ntrepreneurial ventures\, including Synthetic Genomics. He is a former m ember of the Entrepreneurial Council of the Wake Forest Translational Sc ience Institute. He received his M.B.A. from Babson College\, magna cum laude\, where he was a Babson Fellow in the Center for Technology Enterp rise and a Director of the Entrepreneurial Finance Group. He received a B.A. in Biology with a minor in Economics from Colby College.\nEric Gord on\, Founder and CEO of Atentiv has more than 30 years of broad manageri al experience in the pharmaceutical\, biotechnology\, diagnostics and OT C product industries. He has developed strategies with profound industry impact and then provided the leadership to fulfill financial and operat ing objectives. He has taken breakthrough scientific concepts and succes sfully built the infrastructure\, external relationships\, and financial resources to advance them through commercialization and rapid growth. E ric has completed 12 rounds $126M of venture financing\, sold 3 startups \, completed one IPO and returned $1.4B to investors. Atentiv has raised $14.2M of non-dilutive financing and just closed on a $6M Series A Pref erred with angel investors.\nEric is the former founder and CEO of BioBe havioral Diagnostics\, Combinent BioMedical Systems\, Cardium Pharmaceut icals\, and Ardais\, a former CEO of ArQule and Virogenetics\, SVP - San ofi-Pasteur and CFO Sterling Drug. \; He has a background in public accounting and M&\;A at Arthur Andersen. \; Eric received his MBA from the Wharton School\, BS from Syracuse and is a CPA in New York.\nC hristopher Stepanian\, President of WindGap Medical is a serial entrepre neur and an advanced materials design expert. Chris was a co-founder of Aspen Aerogels\, a nanotechnology company that has a pending $115MM IPO on NASDAQ. He has held managerial roles in finance\, operations\, and R& amp\;D in the support of a rapidly growing enterprise. He has a deep bac kground in management\, finance and technology commercialization with si x patents and multiple awards from NASA. Chris received his MBA from the MIT Sloan School as a Sloan Fellow in addition to earning engineering d egrees from Texas A&\;M and Rensselaer Polytechnic Institute. \;\ nFrederic H. Morris is a Partner and Founder at Brook Venture Partners.& nbsp\; Brook is currently investing its Partner Fund III\, making contro l investments in companies in the IT and IT-enabled services sectors wit h revenues of $2 to $30 million and EBITDA of $1 million and over. \ ; Investment size is typically $5 to $10 million. \;\nMr. Morris is on the Board of Intac International\, LLC\; LW Robbins\, Inc.\; Telematc h\, Inc.\; \;PointCare Technologies\, Inc.\; Verge Solutions\, LLC\;  \;Bioscan\, Inc.\; Security Innovation\, Inc.\; \;Laser Project ion Technologies\, Inc.\; and Atlas Watersystems\, Inc. \; He also s erves on the Boards of the North Shore Technology Council and the North Shore InnoVentures. \; Prior to forming Brook\, Mr. Morris founded a nd led the Specialized Lending Division of State Street Bank in Boston w here he was a Senior Vice President and member of the Management Committ ee. \; Mr. Morris holds a BA from Yale and earned his MBA from Harva rd after serving as Lieutenant in the U.S. Navy.\nAbout the North Shore Technology Council \nThe North Shore Technology Council (NSTC) is a non- profit\, volunteer-led organization with a mission to be the leading col laborative for fostering technology businesses in Massachusetts' north-o f-Boston region. \; The council's mission is to build a strong ecosy stem for the success of technology businesses North of Boston by facilit ating collaboration\, networking\, professional growth and economic deve lopment in a collegial fashion. \; The NSTC welcomes the participati on of technology businesses\, senior executive and employees of technolo gy businesses\, entrepreneurs\, companies that support technology busine sses\, academic and governmental units and non profits. \; The counc il is on the Web at www.nstc.org. Its office is at the Cummings Center\, in Beverly\, Massachusetts. For more information call\, 978-335-5234. URL:http://danvers.patch.com/events/venture-and-angel-investment-is-possi ble-insights-from-the-inside-20c8dc9a SUMMARY:Venture and Angel Investment IS Possible: Insights from the Insid e LOCATION:Danversport Yacht Club Marina: 161 Elliott St\, Danvers\, MA END:VEVENT END:VCALENDAR